Suppr超能文献

支原体和脲原体分子检测与刺激性或疼痛性下尿路症状无关。

Mycoplasma and Ureaplasma Molecular Testing Does Not Correlate with Irritative or Painful Lower Urinary Tract Symptoms.

机构信息

Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.

Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

J Urol. 2021 Aug;206(2):390-398. doi: 10.1097/JU.0000000000001750. Epub 2021 Mar 29.

Abstract

PURPOSE

For patients with persistent irritative lower urinary tract symptoms, such as dysuria and urinary frequency, evaluation for the atypical organisms Ureaplasma and Mycoplasma has been a common part of care. However, these species are genitourinary colonizers and have not been established as causative pathogens in chronic lower urinary tract symptoms. We therefore sought to evaluate diagnostic testing patterns for Ureaplasma and Mycoplasma and characterize the associations of these bacteria with irritative lower urinary tract symptoms using molecular detection techniques.

MATERIALS AND METHODS

Ureaplasma/Mycoplasma testing patterns for 2019 were assessed using an anonymized data repository. Clean catch urine specimens (179) were collected prospectively from female and male patients with and without irritative lower urinary tract symptoms. Quantitative polymerase chain reaction evaluated urinary Ureaplasma and Mycoplasma DNA concentrations, while next-generation sequencing assessed the relative abundance of Ureaplasma and Mycoplasma within the urinary bacterial population.

RESULTS

Ureaplasma/Mycoplasma testing was common, with 575 tests performed in 2019 in our community hospital system. In our cohort, Ureaplasma and Mycoplasma were identified in similar proportions in symptomatic and asymptomatic subjects: 25% of female controls and 27% of females with lower urinary tract symptoms and 9.5% of asymptomatic males and 3.3% of men with symptoms (p=0.87 and p=0.91 for females and males, respectively). Regression analysis revealed that both abundance and concentrations of Mycoplasmataceae correlated negatively with a range of irritative lower urinary tract symptoms, including dysuria and urethral pain.

CONCLUSIONS

A statistically significant negative correlation of Ureaplasma/Mycoplasma levels with a variety of lower urinary tract symptoms suggests that polymerase chain reaction-based Mycoplasmataceae detection has little diagnostic benefit in assessment of chronic irritative urinary symptoms.

摘要

目的

对于持续性刺激性下尿路症状(如尿痛和尿频)的患者,评估解脲脲原体和支原体等非典型病原体一直是常规诊疗的一部分。然而,这些物种是泌尿生殖道定植菌,尚未被确认为慢性下尿路症状的致病病原体。因此,我们旨在评估解脲脲原体和支原体的诊断检测模式,并利用分子检测技术,分析这些细菌与刺激性下尿路症状之间的关联。

材料与方法

使用匿名数据存储库评估 2019 年解脲脲原体/支原体检测模式。前瞻性收集了有和无症状的女性和男性患者的清洁中段尿标本(179 份)。定量聚合酶链反应评估了尿液中解脲脲原体和支原体的 DNA 浓度,而下一代测序评估了尿细菌群中解脲脲原体和支原体的相对丰度。

结果

解脲脲原体/支原体检测较为常见,2019 年在我们的社区医院系统中进行了 575 次检测。在我们的队列中,有症状和无症状患者的解脲脲原体和支原体的检出率相似:25%的女性对照组和 27%的下尿路症状女性患者以及 9.5%的无症状男性和 3.3%的有症状男性患者中检出(女性和男性分别为 p=0.87 和 p=0.91)。回归分析显示,支原体科的丰度和浓度均与多种刺激性下尿路症状呈负相关,包括尿痛和尿道疼痛。

结论

解脲脲原体/支原体水平与各种下尿路症状呈显著负相关,这表明聚合酶链反应检测支原体科对评估慢性刺激性尿路症状的诊断获益不大。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验